Astellas-backed Turn Bio is Advancing Epigenetics for Long, Healthy Life Span
Convert Biotechnologies announced Monday morning that it has closed an “oversubscribed” fundraising round primed to usher the company into its future phase of advancement. Switch Bio’s system is primarily based…